Regenity Biosciences welcomes Dr. Mohamed Ramadan as Senior Vice President of Research & Development, bringing more than 20 years of global leadership experience across biomaterials, medical devices, biologics, and combination products.

Mohamed’s career spans R&D, innovation, commercialization, and organizational transformation, with leadership experience at Cleveland Clinic, Lubrizol Life Sciences, and Boston Consulting Group, alongside founding multiple successful ventures. Throughout his career, he has built and led high-performing organizations, advanced innovative technologies from concept to market, established strategic partnerships, and driven operational excellence and sustainable growth.

A polymer chemist by training, Mohamed holds a PhD from Carnegie Mellon University and an MBA from the University of Illinois. He combines scientific depth with strategic vision, disciplined execution, and a strong commitment to people, customers, and clinical impact.

At Regenity, Mohamed will lead the global R&D organization and Project Management Office (PMO), shaping the company’s biomaterials innovation strategy and advancing next-generation implantable biologics, regenerative medicine products, and drug delivery solutions. His focus will be on strengthening R&D capabilities, accelerating product development and commercialization, and deepening OEM co-development partnerships, while building on the scientific expertise and customer-focused culture that define Regenity.

Welcome to Regenity, Mohamed. We’re excited for what lies ahead!